CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cerebral Palsy
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Deglutition Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Exotropia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Little's Disease
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Pyramidal sign
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Impaired cognition
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Spastic Quadriplegia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Supranuclear gaze palsy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Poor speech
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Variable expressivity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus, CTCAE 3.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dilated ventricles (finding)
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Frontotemporal cerebral atrophy
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Nystagmus, CTCAE 5.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypertensive disease
|
0.200 |
Biomarker
|
group |
RGD |
A hypertension-linked decrease of gamma-adducin was confirmed by demonstrating a decrease in gamma-adducin expression in hypothalamic/brainstem neuronal cultures from prehypertensive SH rats.
|
12364392 |
2002 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15).
|
12810632 |
2003 |
Alzheimer's Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
ADDL concentrations for the subjects diagnosed with AD were consistently higher than the levels in the CSF taken from nondemented age-matched controls.
|
15695586 |
2005 |
Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The sclerosing perineuriomas showed 46,XY,t(2;10)(p23;q24) and 47,XX,add(3)(q23),add(6)(q21),-5,-9,-10,-22,+mar1,+mar2,+mars; the intraneural tumor showed 46,XX,add(2)(q11.2),add(3)(q12); and the abdominal soft tissue perineurioma showed 46,XX,t(8;9)(q13;q22).
|
16096405 |
2005 |
Perineurioma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The sclerosing perineuriomas showed 46,XY,t(2;10)(p23;q24) and 47,XX,add(3)(q23),add(6)(q21),-5,-9,-10,-22,+mar1,+mar2,+mars; the intraneural tumor showed 46,XX,add(2)(q11.2),add(3)(q12); and the abdominal soft tissue perineurioma showed 46,XX,t(8;9)(q13;q22).
|
16096405 |
2005 |
Soft tissue perineurioma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The sclerosing perineuriomas showed 46,XY,t(2;10)(p23;q24) and 47,XX,add(3)(q23),add(6)(q21),-5,-9,-10,-22,+mar1,+mar2,+mars; the intraneural tumor showed 46,XX,add(2)(q11.2),add(3)(q12); and the abdominal soft tissue perineurioma showed 46,XX,t(8;9)(q13;q22).
|
16096405 |
2005 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Involvement of ADD3 and C6ORF80 genes were detected, respectively, in myeloid disorders and in T-cell acute lymphoblastic leukemia (T-ALL), whereas the RAP1GDS1 gene was fused to NUP98 in T-ALL.
|
16467868 |
2006 |